Hammill Kevin Austin 4
4 · MARRONE BIO INNOVATIONS INC · Filed May 7, 2018
Insider Transaction Report
Form 4
Hammill Kevin Austin
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-05-07+400,000→ 400,000 totalExercise: $1.73Exp: 2028-05-03→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting twelve months after the Vesting Commencement Date of May 3, 2018, and the remaining shares vesting in equal monthly installments over the remaining 36 months at the rate of 1/48th, subject to Optionee's continued employment.